Virginia Burns

978 total citations · 1 hit paper
10 papers, 716 citations indexed

About

Virginia Burns is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Virginia Burns has authored 10 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Molecular Biology. Recurrent topics in Virginia Burns's work include Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Treatments and Mutations (3 papers) and Protein Hydrolysis and Bioactive Peptides (1 paper). Virginia Burns is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Treatments and Mutations (3 papers) and Protein Hydrolysis and Bioactive Peptides (1 paper). Virginia Burns collaborates with scholars based in United States and Australia. Virginia Burns's co-authors include Cory Batenchuk, Junya Fujimoto, Christopher J. Rivard, Janis M. Taube, Julia A. Bridge, Robert A. Anders, Jamaal Rehman, Eunhee S. Yi, Hong Wu and David L. Rimm and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of Clinical Pathology.

In The Last Decade

Virginia Burns

10 papers receiving 713 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non–Small Cell Lung Cancer

2017 576 citations David L. Rimm, Gang Han et al. JAMA Oncology profile →

Peers

Virginia Burns

ONCOL

PRM

CR

IMMUN

MB

Shruti Agrawal India

Maria Taboada United Kingdom

Joyce Cheng United States

Jeanne Fourie Zirkelbach United States

Giacomo Pelizzari Italy

Nikolaos Syrigos Greece

Oliver Boix Germany

Oyewale O. Abidoye United States

Kristina Lamberg Sweden

Yunhong Tian China

Shruti Agrawal India

Virginia Burns

447 ×0.8

ONCOL

235 ×0.7

PRM

44 ×0.3

CR

137 ×1.0

IMMUN

120 ×1.6

MB

Citations per year, relative to Virginia Burns Virginia Burns (= 1×) peers Shruti Agrawal

Countries citing papers authored by Virginia Burns

Since Specialization

Citations

This map shows the geographic impact of Virginia Burns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia Burns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia Burns more than expected).

Fields of papers citing papers by Virginia Burns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia Burns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia Burns. The network helps show where Virginia Burns may publish in the future.

Co-authorship network of co-authors of Virginia Burns

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia Burns. A scholar is included among the top collaborators of Virginia Burns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia Burns. Virginia Burns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Kuliukas, Lesley, Zoe Bradfield, Ravani Duggan, et al.. (2020). Midwifery students’: Developing an understanding of being ‘with woman’––A qualitative study. Midwifery. 84. 102658–102658. 14 indexed citations

2.

Batenchuk, Cory, Maher Albitar, Kim E. Zerba, et al.. (2018). A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignancies. Journal of Clinical Pathology. 71(12). 1078–1083. 30 indexed citations

3.

Rimm, David L., Gang Han, Janis M. Taube, et al.. (2017). A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non–Small Cell Lung Cancer. JAMA Oncology. 3(8). 1051–1051. 576 indexed citations breakdown →

4.

Batenchuk, Cory, et al.. (2017). Abstract 4015: A comparative study of PD-L1 IHC 22C3 and 28-8 FDA-approved diagnostic assays in cancer. Cancer Research. 77(13_Supplement). 4015–4015. 3 indexed citations

5.

Chandler, Jason C., David Waterhouse, Sharon Wilks, et al.. (2017). P1.01-051 Nivolumab Versus Chemotherapy as Post-Platinum Therapy for Advanced Non-Small Cell Lung Cancer in a Real-world Setting. Journal of Thoracic Oncology. 12(11). S1913–S1914. 2 indexed citations

6.

Victorson, David, et al.. (2016). Acupuncture-Related Quality of Life Changes Using PROMIS Computer Adaptive Tests in a Pragmatic Trial with Oncology and General Integrative Medicine Patients: The Role of Baseline Acupuncture Expectations. The Journal of Alternative and Complementary Medicine. 22(10). 778–787. 7 indexed citations

7.

Hussein, Maen, Donald Richards, Brian Ulrich, et al.. (2016). ORAL01.02: Biopsies in Initial Diagnosis of Non–Small Cell Lung Cancer in US Community Oncology Practices: Implications for First-Line Immunotherapy. Journal of Thoracic Oncology. 11(11). S249–S250. 2 indexed citations

8.

Schechter, Matthew A., Michael Ku Hung Hsieh, J. Will Thompson, et al.. (2014). Phosphoproteomic Profiling of Human Myocardial Tissues Distinguishes Ischemic from Non-Ischemic End Stage Heart Failure. PLoS ONE. 9(8). e104157–e104157. 30 indexed citations

9.

Burns, Virginia, et al.. (2007). Targeting RNA with cysteine-constrained peptides. Bioorganic & Medicinal Chemistry Letters. 18(2). 565–567. 12 indexed citations

10.

Ballard, T. Eric, et al.. (2006). Mimicking the biological activity of diazobenzo[b]fluorene natural products with electronically tuned diazofluorene analogs. Bioorganic & Medicinal Chemistry Letters. 16(19). 5148–5151. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact